PSC
OYST

Piper Sandler & Co’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Piper Sandler & Co’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$14K – 29
2020
Q2 		$14K Buy
+500
New +$15.1K 0.01% 18

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Piper Sandler & Co's OYST Position: Q3 2020 in Review

Piper Sandler & Co sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2020, closing a stake of 500 shares — an estimated $14K sold.

Piper Sandler & Co first reported a position in OYST in Q2 2020 and held it in 1 quarter. The position peaked at $14K in Q2 2020. 66 funds tracked by Wall St. Rank hold OYST as of Q3 2020.

  • Piper Sandler & Co reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Piper Sandler & Co sold 500 Oyster Point Pharma, Inc. Common Stock shares in Q3 2020, an estimated $14K.
  • Piper Sandler & Co first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Piper Sandler & Co's Oyster Point Pharma, Inc. Common Stock position peaked at $14K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2020.

Based on Piper Sandler & Co's 13F filing for Q3 2020, filed 12 Nov 2020.